FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Dem lawmaker calls for TSA to bring back shoes-off airport security policy

Former Fort Bragg employee charged with leaking classified military information to journalist

Wisconsin couple allegedly starved six children for years, forcing them to eat mold, bugs and dog food

Trump seeks to wipe away entire New York civil fraud judgement

Acting AG Todd Blanche Says DOJ Has Over 8,000 Fraud Cases Underway, And It’s the Tip of the Iceberg

Missouri Incumbents Voted Out a Week After Ignoring Public Pressure on Data Center

Suspect in Iryna Zarutska Killing Declared ‘Incapable to Proceed’ in Murder Trial

BREAKING: FBI Arrests Ex-SOCOM Employee Over Leak to Media 48 Hours After Trump Said Justice Was Coming for Leakers – DEVELOPING

Dem senator ripped for ‘smear’ of female activist advocating for Swalwell’s accusers: ‘Very bad look’

Hero High School Principal Takes a Bullet to Stop School Shooter

DOJ Opens Criminal Investigation Into Cassidy Hutchinson, Democrats’ Star Jan. 6 Witness: Report

Top school district slapped with complaint alleging ‘elaborate system’ to keep kids’ gender transitions secret

Fox News Poll: Record number say taxes are too high; government spending seen as wasteful

Married NFL Coach Caught with Female Reporter a Week After Insulting a Player for His Christian Faith

WATCH: Leavitt slaps down critics who called Trump’s Iran threat a bluff

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”